Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2009 Jan;11(1):35-41. doi: 10.1097/GIM.0b013e31818fa2ff.

2.

Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2013 Jul;15(7):517-27. doi: 10.1038/gim.2012.184. Epub 2013 Feb 21.

PMID:
23429431
3.

Microsatellite instability and colorectal cancer.

Geiersbach KB, Samowitz WS.

Arch Pathol Lab Med. 2011 Oct;135(10):1269-77. doi: 10.5858/arpa.2011-0035-RA. Review.

PMID:
21970482
4.

A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.

Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, Frayling I, Hyde C.

Health Technol Assess. 2014 Sep;18(58):1-406. doi: 10.3310/hta18580. Review.

5.

A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory.

van Lier MG, Wagner A, van Leerdam ME, Biermann K, Kuipers EJ, Steyerberg EW, Dubbink HJ, Dinjens WN.

J Cell Mol Med. 2010 Jan;14(1-2):181-97. doi: 10.1111/j.1582-4934.2009.00977.x. Epub 2009 Nov 19. Review.

6.

Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2010 Dec;12(12):839-43. doi: 10.1097/GIM.0b013e3181f872c0.

PMID:
21042222
7.

Application of molecular diagnostics for the detection of Lynch syndrome.

Pino MS, Chung DC.

Expert Rev Mol Diagn. 2010 Jul;10(5):651-65. doi: 10.1586/erm.10.45. Review.

8.

Families at risk for colorectal cancer: risk assessment and genetic testing.

Schoen RE.

J Clin Gastroenterol. 2000 Sep;31(2):114-20. Review.

PMID:
10993425
9.
10.

Genetic testing in gastroenterology: Lynch syndrome.

Grover S, Syngal S.

Best Pract Res Clin Gastroenterol. 2009;23(2):185-96. doi: 10.1016/j.bpg.2009.02.006. Review.

PMID:
19414145
11.

Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.

Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N.

JAMA. 2006 Sep 27;296(12):1507-17. Review.

PMID:
17003399
12.

Hereditary nonpolyposis colorectal cancer identification and surveillance of high-risk families.

Silva RV, Garicochea B, Cotti G, Maranho IC, Cutait R.

Clinics (Sao Paulo). 2005 Jun;60(3):251-6. Epub 2005 Jun 13. Review.

13.

Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.

Sharaf RN, Myer P, Stave CD, Diamond LC, Ladabaum U.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1093-100. doi: 10.1016/j.cgh.2013.04.044. Epub 2013 May 10. Review.

PMID:
23669308
14.

[Tumour examination to detect hereditary colorectal cancer].

Hoogerbrugge N, Hermens RP, Nagengast F, Overbeek L, van Krieken HJ, Ligtenberg M.

Ned Tijdschr Geneeskd. 2012;156(42):A4982. Review. Dutch.

PMID:
23075775
15.

Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2014 Apr;16(4):338-46. doi: 10.1038/gim.2013.141. Epub 2013 Sep 26. Review.

PMID:
24071797
16.

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f.

PMID:
21150787
17.

Prostate cancer screening in BRCA and Lynch syndrome mutation carriers.

Castro E, Goh CL, Eeles RA.

Am Soc Clin Oncol Educ Book. 2013. doi: 10.1200/EdBook_AM.2013.33.e50. Review.

18.

Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome.

Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN.

Fam Cancer. 2005;4(3):255-65. Review.

PMID:
16136387
19.

Advances in the study of Lynch syndrome in China.

Lu JY, Sheng JQ.

World J Gastroenterol. 2015 Jun 14;21(22):6861-71. doi: 10.3748/wjg.v21.i22.6861. Review.

20.

[Clinicopathological screening of Lynch syndrome: a report of 2 cases and literature review].

Si JW, Wang L, Ba XJ, Zhang X, Dong Y, Zhang JX, Li WT, Li T.

Beijing Da Xue Xue Bao. 2015 Oct 18;47(5):858-64. Review. Chinese.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk